204 related articles for article (PubMed ID: 16860046)
1. Greater inhibition of the pituitary--ovarian axis in oral contraceptive regimens with a shortened hormone-free interval.
Willis SA; Kuehl TJ; Spiekerman AM; Sulak PJ
Contraception; 2006 Aug; 74(2):100-3. PubMed ID: 16860046
[TBL] [Abstract][Full Text] [Related]
2. Pituitary-ovarian hormone levels and symptoms in oral contraceptive users: comparison of a 21/7-day and extended regimen.
Kuehl TJ; Speikermann AM; Willis SA; Coffee A; Sulak PJ
J Reprod Med; 2008 Apr; 53(4):266-70. PubMed ID: 18472649
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of pituitary-ovarian axis suppression with three oral contraceptive regimens.
Vandever MA; Kuehl TJ; Sulak PJ; Witt I; Coffee A; Wincek TJ; Reape KZ
Contraception; 2008 Mar; 77(3):162-70. PubMed ID: 18279685
[TBL] [Abstract][Full Text] [Related]
4. Effects on serum hormone levels of low-dose estrogen in place of placebo during the hormone-free interval of an oral contraceptive.
Reape KZ; DiLiberti CE; Hendy CH; Volpe EJ
Contraception; 2008 Jan; 77(1):34-9. PubMed ID: 18082664
[TBL] [Abstract][Full Text] [Related]
5. Laboratory criteria for menopause in women using oral contraceptives.
Creinin MD
Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618
[TBL] [Abstract][Full Text] [Related]
6. Pituitary and ovarian hormone activity during the 7-day hormone-free interval of various combined oral contraceptive regimens.
Cho M; Atrio J; Lim AH; Azen C; Stanczyk FZ
Contraception; 2014 Jul; 90(1):94-6. PubMed ID: 24594430
[TBL] [Abstract][Full Text] [Related]
7. FSH and ovarian response: spontaneous recovery of pituitary-ovarian activity during the pill-free period vs. exogenous recombinant FSH during high-dose combined oral contraceptives.
van Heusden AM; Coelingh Bennink HJ; Fauser BC
Clin Endocrinol (Oxf); 2002 Apr; 56(4):509-17. PubMed ID: 11966744
[TBL] [Abstract][Full Text] [Related]
8. Comparison of serum and cervical mucus hormone levels during hormone-free interval of 24/4 vs. 21/7 combined oral contraceptives.
Fels H; Steward R; Melamed A; Granat A; Stanczyk FZ; Mishell DR
Contraception; 2013 Jun; 87(6):732-7. PubMed ID: 23352800
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effect of obesity on gonadotropin, estradiol, and inhibin B levels in fertile women.
De Pergola G; Maldera S; Tartagni M; Pannacciulli N; Loverro G; Giorgino R
Obesity (Silver Spring); 2006 Nov; 14(11):1954-60. PubMed ID: 17135611
[TBL] [Abstract][Full Text] [Related]
10. Dimeric inhibin serum values as markers of ovarian activity in pill-free intervals.
Renier MA; Vereecken A; Van Herck E; Straetmans D; Ramaekers P; Vanderheyden J; Degezelle H; Buytaert P
Contraception; 1998 Jan; 57(1):45-8. PubMed ID: 9554250
[TBL] [Abstract][Full Text] [Related]
11. [Ultrasonic and hormonal monitoring of the ovaries during mini-dose oral contraception].
Doyen J; Schaaps JP; Lambotte R
Contracept Fertil Sex (Paris); 1987 May; 15(5):529-33. PubMed ID: 12268693
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of extended oral contraceptive regimens with a shortened hormone-free interval to manage breakthrough bleeding.
Sulak PJ; Carl J; Gopalakrishnan I; Coffee A; Kuehl TJ
Contraception; 2004 Oct; 70(4):281-7. PubMed ID: 15451331
[TBL] [Abstract][Full Text] [Related]
13. [Clinico-laboratory research on the pharmacodynamic characteristics of Rigevidon].
Korkhov VV; Nikanorova SA
Farmakol Toksikol; 1987; 50(1):97-100. PubMed ID: 3556564
[TBL] [Abstract][Full Text] [Related]
14. Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Müllerian hormone and small antral follicle count using three-dimensional ultrasound.
Deb S; Campbell BK; Pincott-Allen C; Clewes JS; Cumberpatch G; Raine-Fenning NJ
Ultrasound Obstet Gynecol; 2012 May; 39(5):574-80. PubMed ID: 21997961
[TBL] [Abstract][Full Text] [Related]
15. Inhibin B and ovarian function after total abdominal hysterectomy in women of reproductive age.
Nahás E; Pontes A; Traiman P; NahásNeto J; Dalben I; De Luca L
Gynecol Endocrinol; 2003 Apr; 17(2):125-31. PubMed ID: 12737673
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of hormonal suppression with two contraceptive regimens using ethinyl estradiol and desogestrel.
Gassen DT; Herter LD; Chagas JK; Schmid H
Arch Gynecol Obstet; 2013 Feb; 287(2):289-94. PubMed ID: 22976131
[TBL] [Abstract][Full Text] [Related]
17. Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study.
Duijkers IJ; Klipping C; Verhoeven CH; Dieben TO
Hum Reprod; 2004 Nov; 19(11):2668-73. PubMed ID: 15333593
[TBL] [Abstract][Full Text] [Related]
18. Interrelationships of estradiol, inhibin, and gonadotropins during follicle deviation in pony mares.
Donadeu FX; Ginther OJ
Theriogenology; 2004 May; 61(7-8):1395-405. PubMed ID: 15036971
[TBL] [Abstract][Full Text] [Related]
19. Alterations in the ability of the bovine pituitary gland to secrete gonadotropins in vitro during the first follicle-stimulating hormone increase of the estrous cycle and in response to exogenous steroids.
Lane EA; Padmanabhan V; Roche JF; Crowe MA
Domest Anim Endocrinol; 2005 Feb; 28(2):190-201. PubMed ID: 15713366
[TBL] [Abstract][Full Text] [Related]
20. [Usefulness of serum inhibin B measurement for evaluation of ovarian reserve in controlled ovarian hyperstimulation].
Wu RR; Liao YC; Ye Y; Du Y; Ke WN; Zhang XB; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2005 Oct; 40(10):679-81. PubMed ID: 16277899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
